This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Lanh Green, RPh, MPH; John Clark, MD, MSPH
Food and Drug Administration Rockville, Md

JAMA. 1989;262(17):2383.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Many drugs, including the new broad-spectrum fluoroquinolone anti-infective agents, are known to interfere with theophylline metabolism by the hepatic cytochrome P450 system, causing toxic reactions to theophylline. Wijnands et al¹ reported increases in plasma theophylline concentrations during coadministration of enoxacin (110.9%) and to a lesser degree during coadministration of ciprofloxacin (22.8%) and pefloxacin (19.6%). Although two recent pharmacokinetic studies^2,3 suggest that a drug-drug interaction between norfloxacin and theophylline also exists, we are not aware of any case reports of elevated theophylline levels associated with this drug in the medical literature.

Three cases have been reported to the Food and Drug Administration that suggest theophylline toxic effects in patients taking norfloxacin. Each patient had a baseline steady-state theophylline level that was increased by at least 50% after starting norfloxacin therapy. A judgment was made that concomitant drugs or diseases were not likely to be responsible. All . . . [Full Text PDF of this Article]

Footnotes
Edited by Drummond Rennie, MD, Deputy Editor (West), and Don Riesenberg, MD, Senior Editor.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?